Cansativa’s €13 Million Series B Financing Round

YPOG advised Cansativa on the deal. Noerr advised Casa Verde Capital, with leading Canadian law firm Osler, Hoskin & Harcourt.

Canastiva closed its recent Series B financing round. The investment has a total volume of €13 million and was led by Casa Verde, with participation from Argonautic Ventures and Munich-based family office Alluti.

Cansativa is, amongst others, the exclusive distributor of the Cannabis Agency at the Federal Institute for Drugs and Medical Devices (BfArM) for domestically grown medical cannabis. The company will use the funding to expand its medical cannabis product portfolio and to develop its platform for consumer recreational use in the anticipation of legalization in Germany. The fund, initiated by rapper Snoop Dogg, regularly invests in up-and-coming companies in the cannabis segment. The investment in Cansativa is Casa Verde’s largest investment to date in Europe.

The YPOG team included Dr. Benjamin Ullrich (Picture – Co-Lead, Transactions), Partner; Dr. Johannes Janning (Co-Lead, Transactions), Associated Partner.

The Noerr team included Felix Blobel (Private Equity, Berlin), Daniel Fuchs (Berlin), Susann Jahn (Dresden).

The Osler team was led by Gary Marshall (Emerging and High Growth Companies, Toronto).

Involved fees earner: Felix Blobel – Noerr; Daniel Fuchs – Noerr; Susann Jahn – Noerr; Gary Marshall – Osler Hoskin & Harcourt; Johannes Janning – YPOG; Benjamin Ullrich – YPOG;

Law Firms: Noerr; Osler Hoskin & Harcourt; YPOG;

Clients: Cansativa GmbH; Casa Verde Capital;

Federica Tiefenthaler

Author: Federica Tiefenthaler